
Image Courtesy SDSU
Valentine’s Day has finally come and gone. Did you perhaps live one of the horror stories that we’ve all heard before? Horrible date? Bad break up? Suffering from the broken heart malady that I mentioned in just my last post? <Yeah, I know I’ll quit with the cheesy broken heart metaphors after this week.>
While a broken heart may be a real ailment, cardiac disease and heart attacks are a much more serious business. Luckily, some recent work is out there to give us hope.
Chocolates? Check. Card? Check. Dinner reservations? Done and done. Dozen roses? Two dozen? Hell, I don’t know how much you make – personally, I’m on a grad student stipend. Carnations, perhaps? Regardless, fellas, you better be on your A game today.
Stem cells seem to be at the forefront of endless avenues of controversy these days, but the promise that they could hold for treatment of a range of diseases, often gets lost in the shuffle. The debate, of course, comes in when discussing the use and study of embryonic stem cells, for obvious reasons. However, not all “stem cell research” should get slapped with the connotations that embryonic research is saddled with. Plenty of amazing work is being done to investigate stem cell therapeutics in a range of contexts, and here I present a promising preclinical study that was published in